Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;11(1):107–116. doi: 10.1111/j.1750-3639.2001.tb00385.x

The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System

Glenn K Matsushima 1,2,✉, Pierre Morell 1,3
PMCID: PMC8098267  PMID: 11145196

Abstract

Myelin of the adult CNS is vulnerable to a variety of metabolic, toxic, and autoimmune insults. That remyelination can ensue, following demyelinating insult, has been well demonstrated. Details of the process of remyelination are, however difficult to ascertain since in most experimental models of demyelination/remyelination the severity, localization of lesion site, or time course of the pathophysiology is variable from animal to animal. In contrast, an experimental model in which massive demyelination can be reproducibly induced in large areas of mouse brain is exposure to the copper chelator, cuprizone, in the diet. We review work from several laboratories over the past 3 decades, with emphasis on our own recent studies, which suggest an overall picture of cellular events involved in demyelination/remyelination. When 8 week old C57BL/6 mice are fed 0.2% cuprizone in the diet, mature olidgodendroglia are specifically insulted (cannot fulfill the metabolic demand of support of vast amounts of myelin) and go through apoptosis.This is closely followed by recruitment of microglia and phagoctytosis of myelin. Studies of myelin gene expression, coordinated with morphological studies, indicate that even in the face of continued metabolic challenge, oligodendroglial progenitor cells proliferate and invade demyelinated areas. If the cuprizone challenge is terminated, an almost complete remyelination takes place in a matter of weeks. Communication between different cell types by soluble factors may be inferred. This material is presented in the context of a model compatible with present data—and which can be tested more rigorously with the cuprizone model. The reproducibility of the model indicates that it may allow for testing of manipulations (e.g. available knockouts or transgenics on the common genetic background, or pharmacological treatments) which may accelerate or repress the process of demyelination and or remyelination.

Full Text

The Full Text of this article is available as a PDF (307.7 KB).

References

  • 1. Bakker DA, Ludwin SK (1987) Blood‐brain barrier permeability during cuprizone‐induced demyelination. Implications for the pathogenesis of immune‐mediated demyelinating diseases. J Neurol Sci 78:125–137. [DOI] [PubMed] [Google Scholar]
  • 2. Blakemore W (1972) Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1:413–426. [DOI] [PubMed] [Google Scholar]
  • 3. Blakemore WF (1973a) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J Neurol Sci 20:73–83. [DOI] [PubMed] [Google Scholar]
  • 4. Blakemore WF (1973b) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20:63–72. [DOI] [PubMed] [Google Scholar]
  • 5. Blakemore WF (1974) Remyelination of the suprerior cerebellar peduncle in old mice following demyelination induced by cuprizone. J Neurol Sci 22:121–127. [DOI] [PubMed] [Google Scholar]
  • 6. Blakemore WF (1984) The response of oligodendrocytes to chemical injury. Acta Neurologica Scandinavica Supplement 100:33–38. [PubMed] [Google Scholar]
  • 7. Bornstein MB, Raine C (1970) Experimental allergic encephalomyelitis antiserum inhibition of myelination in vitro . Lab Invest 23:536–539. [PubMed] [Google Scholar]
  • 8. Cammer W (1999) The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro . J Neurol Sci 168:116–120. [DOI] [PubMed] [Google Scholar]
  • 9. Cammer W, Zhang H (1993) Atypical localization of the oligodendrocytic isoform (PI) of glutathione‐S‐transferase in astrocytes during cuprizone intoxication. J Neurosci Res 36:183–190. [DOI] [PubMed] [Google Scholar]
  • 10. Cammer W, Zhang H, Tansey FA (1995) Effects of carbonic anhydrase II (CAII) deficiency on CNS structure and function in the myelin‐deficient CAII‐deficient double mutant mouse. J Neurosci Res 40:451–457. [DOI] [PubMed] [Google Scholar]
  • 11. Carey EM, Freeman NM (1983) Biochemical changes in cuprizone‐induced spongiform encephalopathy. Neurochem Res 8:1029–1044. [DOI] [PubMed] [Google Scholar]
  • 12. Carlton WW (1967) Studies on the induction of hydro‐cephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. Life Sci 6:11–19. [DOI] [PubMed] [Google Scholar]
  • 13. Carlton WW (1969) Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. Exper Mol Pathol 10:274–287. [DOI] [PubMed] [Google Scholar]
  • 14. Elsworth S, Howell JM (1973) Variation in the response of mice to cuprizone. Res Vet Sci 14:385–387. [PubMed] [Google Scholar]
  • 15. Fujita N, Ishiguro H, Sato S, Kurihara T, Kuwano R, Sakimura K, Takahashi Y, Miyatake T (1990) Induction of myelin‐associated glycoprotein mRNA in experimental remyelination. Brain Res 513:152–155. [DOI] [PubMed] [Google Scholar]
  • 16. Gao X, Matsushima G, Popko B (2000) Interferon gamma protects against cuprizone‐induced demyelination. Mol Cell Neurosci In Press. [DOI] [PubMed] [Google Scholar]
  • 17. Hiremath MM, Saito Y, Knapp GW, Ting JP‐Y, Suzuki K, Matsushima GK (1998) Microglial/macrophage accumulation during cuprizone‐induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38–49. [DOI] [PubMed] [Google Scholar]
  • 18. Jurevics HA, Hostettler J, Matsushima GK, Toews AD, and Morell P (2000) Lipid metabolism during remyelination in brain. J Neurochem 74:S32. [Google Scholar]
  • 19. Kesterson JW, Carlton WW (1971) Histopatholoic and enzyme histochemical observations of the cuprizone‐induced brain edema. Exper Mol Pathol 15:82–96. [DOI] [PubMed] [Google Scholar]
  • 20. Komoly S, Hudson LD, Webster HD, Bondy CA (1992) Insulin‐like growth factor 1 gene expression is induced in astrocytes during experimental demyelination. Proc Nat Acad Sci USA 89:1894–1898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Komoly S, Jeyasingham MD, Pratt OE, Lantos PL (1987) Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J Neurol Sci 78:125–137. [DOI] [PubMed] [Google Scholar]
  • 22. Kondo A, Nakano T, Suzuki K (1987) Blood‐brain barrier permeability to horseradish peroxidase in twitcher and cuprizone‐intoxicated mice. Brain Res 425:186–190. [DOI] [PubMed] [Google Scholar]
  • 23. Love S (1988) Cuprizone neurotoxicity in the rat: morphologic observations. J Neurol Sci 84:223–237. [DOI] [PubMed] [Google Scholar]
  • 24. Ludwin S (1994) Central nervous system remyelination: studies in chronically damaged tissue. Ann Neurol 36 Suppl:143–145. [DOI] [PubMed] [Google Scholar]
  • 25. Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse. An ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612. [PubMed] [Google Scholar]
  • 26. Ludwin SK (1979) An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Pathol 95:683–696. [PMC free article] [PubMed] [Google Scholar]
  • 27. Ludwin SK (1980) Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 43:382–387. [PubMed] [Google Scholar]
  • 28. Ludwin SK, Sternberger NH (1984) An immunohistochemical study of myelin proteins during remyelination in the central nervous system. Acta Neuropathol 63:240–248. [DOI] [PubMed] [Google Scholar]
  • 29. Mason JL, Jones J, Taniike M, Morell P, Suzuki K, Matsushima GK (2000) Mature oligodendrocyte apoptosis precedes IGF‐1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251–262. [DOI] [PubMed] [Google Scholar]
  • 30. Mason JL, Ye P, Suzuki K, D'Ercole AJ Matsushima GK (2000) Insulin like growth factor‐1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703–5708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Miller DJ, Asakura K, Rodriguez M (1996) Central nervous system remyelination clinical application of basic neruoscience principles. Brain Pathol 6:331–344. [DOI] [PubMed] [Google Scholar]
  • 32. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK (1998) Gene expression in the brain during cuprizone‐induced demyelination and remyelination. Mol Cell Neurosci 12:220–227. [DOI] [PubMed] [Google Scholar]
  • 33. Muse ED, Jurevics H, Toews AD, Matsushima GK, Morell P (2000) Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem In Press. [DOI] [PubMed] [Google Scholar]
  • 34. Nishiyama A, Lin X‐H, Giese N, Heldin C‐H, Stallcup WB (1996) Co‐localization of NG2 proteoglycan and PDGFa‐receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299–314. [DOI] [PubMed] [Google Scholar]
  • 35. Pattison IH, Jebbett JN (1971) Clinical and histological observations on cuprizone toxicity and scrapie in mice. Res Vet Sci 12:378–380. [PubMed] [Google Scholar]
  • 36. Pattison IH, Jebbett JN (1973) Unsuccessful attempts to produce disease with tissues from mice fed on a diet containing cuprizone. Res Vet Sci 14:128–130. [PubMed] [Google Scholar]
  • 37. Smith M (1999) Phagocytosis of myelin in demyelinating disease: A review. Neurochem Res 24:261–268. [DOI] [PubMed] [Google Scholar]
  • 38. Streit WJ, Walter SA, Pennell NA (1999) Reactive microgliosis. Prog Neurobiol 57:563–581. [DOI] [PubMed] [Google Scholar]
  • 39. Suzuki K (1969b) Giant hepatic mitochondria: production in mice fed with cuprizone. Science 163:81–82. [DOI] [PubMed] [Google Scholar]
  • 40. Suzuki K, Kikkawa T (1969a) Status spongiosus of CNS and hepatic changes induced by curpizone (biscyclo‐hexanone oxalyldihydrazone). Am J Pathol 54:307–325. [PMC free article] [PubMed] [Google Scholar]
  • 41. Tansey FA, Cammer W (1991) A Pi form of glutathione‐s‐transferase is a myelin‐ and oligodendrocyte‐associated enzyme in mouse brain. J Neurochem 57:95–102. [DOI] [PubMed] [Google Scholar]
  • 42. Venezie RD, Toews A, Morell P (1995) Macrophage recruitment in different models of nerve injury: lysozyme as a marker for active phagocytosis. J Neurosci Res 40:99–107. [DOI] [PubMed] [Google Scholar]
  • 43. Venturini G (1973) Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo . J Neurochem 21:1147–1151. [DOI] [PubMed] [Google Scholar]
  • 44. Walshe JM (1995) Copper: not too little, not too much, but just right. J R Coll Phys Lond 29:280–283. [PMC free article] [PubMed] [Google Scholar]
  • 45. Zlotkin SH, Atkinson S, Lockitch G (1995) Trace elements in nutrition for permature infants. Clin Perinatol 22:223–240. [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES